US
George Clinical – CRO Malaysia – George Clinical

Malaysia

Malaysia is George Clinical’s Southeast Asian hub, where we cover neighboring countries of Singapore, Indonesia and the Philippines – accessing a population of almost 400 million multi-ethnic people.

George Clinical In Malaysia

Malaysia is George Clinical’s Southeast Asian hub, where we cover neighboring countries of Singapore, Indonesia and the Philippines – accessing a population of almost 400 million multi-ethnic people.

Singapore is a recognized destination for clinical trials, yet other countries are fast emerging as more governments commit to streamlining their clinical research industry. Malaysia implements a universal healthcare system that co-exists with a private healthcare system. Malaysia has a multi-ethnic population of over 30 million, with moderate life expectancy and infant mortality rate. The government has committed funding to improve the healthcare systems in order to support medical tourism and clinical research. The network of Clinical Research Centres, as well as Clinical Research Malaysia, is part of the government effort to improve the country’s infrastructure to support the industry. To date, Malaysia has 90 industry-sponsored research (ISR) trial sites which are approved by the Ministry of Health (MOH) and local IRBs/ IECs, consisting of 11 prime sites network. They are a mixture of public, teaching and private hospitals, and have participated in over 1,000 ISR trials that require ICH GCP compliance.

Why is the country attractive for sponsors to conduct clinical trials?

  • The current Malaysian Economic Transformation Program (ETP) targets clinical research as one of its main drivers in economic growth. Therefore, the government of Malaysia established Clinical Research Malaysia (CRM) with the aim of promoting an increase in the number of clinical trials in Malaysia.
  • CRM supports the clinical research industry to effectively increase the speed, reliability, and delivery of outcomes for all stakeholders involved.
  • Malaysia has inherent benefits to conduct clinical trials such as its large multi-ethnic population that offers genetic diversity
  • Established and good public and private healthcare systems 
  • A consistently increasing number of Good Clinical Practice (GCP) trained and compliant investigators and support staff
  • An established and comprehensive ethical review process by ethics committees 
  • Adherence to intellectual property rights (IPRs) and competitive trial costs compared to other Asian countries. 
  • Malaysia also boasts shorter regulatory and ethics approval timelines for ISR that are comparable with countries like Hong Kong, Japan, Singapore, Taiwan and South Korea
  • Malaysia ranks high globally with one of the best start-up timelines  

Why is George Clinical the CRO of choice for our sponsors in Malaysia?

  1. Established in-country network 
  2. Experienced staff on local regulations and requirement
  3. Engagement with key opinion leaders (KOLs) across various therapeutic areas

Contact

George Clinical Address:
Unit 902, Level 9, Uptown 2
No 2, Jalan SS 21/37
Damansara Uptown
47400 Petaling Jaya
Selangor DE
Malaysia

East Asia Contact Number: +60 (3) 7610 0725

Details

Population 32.07 million, multi-ethnic
Official Language Bahasa Malaysia (official), English, Chinese (Cantonese, Mandarin, Hokkien, Hakka, Hainan, Foochow), Tamil, Telugu, Malayalam, Panjabi, Thai
Hospital Records Language Mostly English
Electronic Hospital Records Available in selected number of public, teaching and private hospitals only
Site Network 90 hospitals sites, mixture of public, teaching hospital and private
In-country services Clinical Operations
Regulatory Services